DELVE
Flagship Labs 89, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 98254371 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Name | Christina M. Licursi |
| Attorney Docket Number | F20782000200 |
Timeline
| 2023-11-03 | Application Filed |
| 2023-11-27 | Location: NEW APPLICATION PROCESSING |
| 2023-11-27 | Status: Live/Pending |
| 2023-11-27 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Flagship Labs 89, Inc. |
| Address | 55 Cambridge Parkway, Suite 800E Cambridge DE 02142 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 005,006,018,044,046,051,052 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceuticals; therapeutics; scientific and medical research and development; research and development in the field of computational biology, bioinformatics, genetics, genomics, biotechnology, pharmaceuticals, and therapeutics; drug discovery platform; pharmaceutical and biopharmaceutical research and development; drug development services, namely, pharmaceutical drug development services; development of pharmaceuticals and therapeutic agents for others, namely, development of pharmaceutical preparations and medicines; scientific research and development in the field of computational biology, bioinformatics, genetics, genomics, biotechnology and pharmaceuticals; platform as a service (PAAS) featuring computer software platforms for research and development of pharmaceutical data in the field of computational biology, bioinformatics, genetics, genomics, biotechnology and pharmaceuticals; DNA, RNA, and genomic analysis and sequencing services for scientific, medical, and research purposes |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-11-27 | 1 NWOS I:Incoming Correspondence |
| AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | 2023-12-06 | 2 ASGN I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2024-01-19 | 3 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2024-01-24 | 4 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-01-24 | 5 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-01-24 | 6 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2024-01-26 | 7 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2024-01-26 | 8 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2024-01-26 | 9 TEME I:Incoming Correspondence |
| NON-FINAL ACTION WRITTEN | 2024-03-04 | 10 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2024-03-04 | 11 GNRT O:Outgoing Correspondence |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2024-03-04 | 12 GNRN O:Outgoing Correspondence |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 